Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.12
27.09.23
-
27.09.24
-35.70%
30.09.23

Risky Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.54
26.09.23
-
26.09.24
20.23%
27.09.23

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.47
26.09.23
-
26.09.24
-26.87%
15.10.23

Could be very worthwhile Investment >20% year
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€4.95
19.09.23
-
19.09.24
0.10%
02.10.23

Palatin Technologies Inc.

Start price
Target price
Perf. (%)
€1.81
16.09.23
€1.00
16.09.24
-22.10%
30.09.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Ose Pharma International S.A.

Start price
Target price
Perf. (%)
€5.11
16.09.23
€2.00
16.09.24
-14.09%
30.09.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€2.58
16.09.23
€1.00
16.09.24
-11.84%
30.09.23

BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€1.74
16.09.23
€1.00
16.09.24
-5.75%
30.09.23

buy
Ose Pharma International S.A.

Start price
Target price
Perf. (%)
€6.87
13.09.23
-
13.09.24
-27.22%
15.09.23

BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€2.40
11.09.23
-
11.09.24
-22.50%
12.09.23

Probably not worthwhile Investment
buy
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€2.14
09.09.23
€3.00
09.09.24
-18.69%
16.09.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
buy
AC Immune Ltd

Start price
Target price
Perf. (%)
€3.25
04.09.23
-
04.09.24
7.86%
11.12.23

Could be worthwhile Investment >10% per year
buy
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€1.97
04.09.23
-
04.09.24
-16.75%
01.10.23

BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€1.97
03.09.23
-
03.09.24
-21.32%
13.09.23

Risky Investment
buy
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€1.97
03.09.23
€2.50
31.07.25
18.78%
06.09.23

Could be very worthwhile Investment >20% year
buy
Lisata Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.94
03.09.23
-
03.09.24
1.03%
16.09.23

buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€1.01
03.09.23
-
03.09.24
-19.80%
05.11.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.67
02.09.23
€17.00
02.09.24
-5.50%
16.09.23

ifa systems AG

Start price
Target price
Perf. (%)
€3.16
20.08.23
€0.000
20.08.24
-5.70%
03.09.23

Revenue decline/stagnation expected
Decining EBIT margin than peer group
EBIT decline/stagnation expected
High valuation
buy
Check Cap Ltd

Start price
Target price
Perf. (%)
€2.42
17.08.23
-
17.08.24
2.48%
20.08.23

Tabula Rasa HealthCare Inc

Start price
Target price
Perf. (%)
€9.35
08.08.23
-
08.08.24
5.88%
11.12.23

Probably not worthwhile Investment
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€1.28
06.08.23
-
06.08.24
-12.50%
20.08.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Shin Nippon Biomedical Laboratories Ltd.

Start price
Target price
Perf. (%)
€13.30
02.08.23
-
02.08.26
12.03%
08.08.23

buy
Seelos Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.37
31.07.23
-
25.08.26
-89.21%
24.11.23

buy
Seelos Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.29
24.07.23
-
24.08.23
6.44%
31.07.23